Back to Search
ELIZABETH TAN-CHIU, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1538113931IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
ME73690(FL)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
ME73690(FL)
Education
OTHER
Class of 1986
Research & Publications (19)
Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.
PMID 12591986·J Natl Cancer Inst·2003
8-other
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
PMID 19349550·J Clin Oncol·2009
3-trial
Single-agent lapatinib for HER2-overexpressing advanced or metastatic breast cancer that progressed on first- or second-line trastuzumab-containing regimens.
PMID 19179558·Ann Oncol·2009
3-trial
Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?
PMID 18048835·J Clin Oncol·2007
8-other
Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer.
PMID 17159193·J Clin Oncol·2007
4-observational
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
PMID 16648502·J Clin Oncol·2006
2-rct
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.
PMID 16258083·J Clin Oncol·2005
4-observational
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.
PMID 16236738·N Engl J Med·2005
3-trial
Trastuzumab plus chemotherapy: convincing survival benefit or not?
PMID 15911863·J Clin Oncol·2005
8-other
Response to fulvestrant in heavily pretreated postmenopausal women: a single-center experience.
PMID 15564793·Breast Cancer Res Treat·2004
3-trial
Lower-category benign breast disease and the risk of invasive breast cancer.
PMID 15100339·J Natl Cancer Inst·2004
8-other
Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience.
PMID 12048273·J Natl Cancer Inst·2002
8-other
Breast cancer chemoprevention: current status and future directions.
PMID 11402435·Semin Oncol·2001
6-review
Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06.
PMID 11309768·Cancer·2001
3-trial
Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
PMID 11208880·J Natl Cancer Inst·2001
1-meta
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.
PMID 11181655·J Clin Oncol·2001
3-trial
Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.
PMID 11136837·J Natl Cancer Inst·2001
3-trial
HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15.
PMID 11121461·J Natl Cancer Inst·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR
TAMPA, FL 33612 - Phone
- (866) 837-4112
Quick Facts
- NPI
- 1538113931
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 40
- Publications
- 19
Are you this provider?
Claim Your Profile